Use of aspirin as sole oral antiplatelet therapy in acute flow diversion for ruptured dissecting aneurysms

Albert Ho Yuen Chiu, Rajalakshmi Ramesh, Jason Wenderoth, Mark Davies, Andrew Cheung

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Subarachnoid hemorrhage secondary to rupture of a circumferential dissecting aneurysm continues to be a treatment dilemma. Vessel sacrifice, when possible, continues to be the safest option but in certain cases this is not possible due to lack of collateral supply. In such cases, coil assisted endovascular flow diversion has become a potential option but the requirement for dual antiplatelet therapy in an unsecured intracranial aneurysm continues to raise concern.We present a 48-year-old man with a World Federation of Neurological Surgeons grade 5 subarachnoid hemorrhage, secondary to a ruptured intradural left vertebral artery dissecting aneurysm, who was treated successfully with a pipeline embolization device with Shield technology using aspirin and a single intravenous loading dose of abciximab. To our knowledge, this is the first case of an acute flow diversion performed using only aspirin as the sole oral antiplatelet agent.

Original languageEnglish
Pages (from-to)e18
JournalJournal of neurointerventional surgery
Volume9
Issue number5
DOIs
Publication statusPublished - 1 May 2017
Externally publishedYes

Take-down notice

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Fingerprint Dive into the research topics of 'Use of aspirin as sole oral antiplatelet therapy in acute flow diversion for ruptured dissecting aneurysms'. Together they form a unique fingerprint.

  • Cite this